Published in J Virol on September 22, 2010
Tetherin restricts direct cell-to-cell infection of HIV-1. Retrovirology (2010) 1.34
β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release. Retrovirology (2011) 1.07
A single nucleotide polymorphism in tetherin promotes retrovirus restriction in vivo. PLoS Pathog (2012) 1.06
Tetherin inhibits prototypic foamy virus release. Virol J (2011) 1.02
BST-2/tetherin-mediated restriction of chikungunya (CHIKV) VLP budding is counteracted by CHIKV non-structural protein 1 (nsP1). Virology (2013) 0.98
Innate immunity in acute HIV-1 infection. Curr Opin HIV AIDS (2011) 0.95
Cell-to-cell transmission of retroviruses: Innate immunity and interferon-induced restriction factors. Virology (2011) 0.93
Assembly and replication of HIV-1 in T cells with low levels of phosphatidylinositol-(4,5)-bisphosphate. J Virol (2011) 0.89
Tetherin and its viral antagonists. J Neuroimmune Pharmacol (2011) 0.87
The highly polymorphic cyclophilin A-binding loop in HIV-1 capsid modulates viral resistance to MxB. Retrovirology (2015) 0.86
TLR-4 engagement of dendritic cells confers a BST-2/tetherin-mediated restriction of HIV-1 infection to CD4+ T cells across the virological synapse. Retrovirology (2013) 0.83
The role of BST-2/Tetherin in host protection and disease manifestation. Immun Inflamm Dis (2015) 0.79
HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer. J Virol (2016) 0.78
Identification of novel key amino acids at the interface of the transmembrane domains of human BST-2 and HIV-1 Vpu. Retrovirology (2013) 0.77
In COS cells Vpu can both stabilize tetherin expression and counteract its antiviral activity. PLoS One (2014) 0.77
A small molecule compound IMB-LA inhibits HIV-1 infection by preventing viral Vpu from antagonizing the host restriction factor BST-2. Sci Rep (2015) 0.77
2-thio-6-azauridine inhibits Vpu mediated BST-2 degradation. Retrovirology (2016) 0.76
Antiviral potency and functional analysis of tetherin orthologues encoded by horse and donkey. Virol J (2014) 0.75
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature (2002) 21.53
The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature (2004) 17.56
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature (2008) 14.99
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother (2002) 13.91
Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci U S A (1991) 10.05
The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe (2008) 9.27
HIV-1 gag proteins: diverse functions in the virus life cycle. Virology (1998) 7.32
p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J Virol (1995) 6.87
The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J Virol (1990) 6.08
Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic (2003) 5.32
Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell (2009) 5.06
Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J Virol (2008) 4.72
Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc Natl Acad Sci U S A (2009) 4.38
HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor. Cell Host Microbe (2009) 4.36
Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog (2009) 4.24
Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe (2009) 4.11
Inhibition of Lassa and Marburg virus production by tetherin. J Virol (2008) 3.98
The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. J Virol (1994) 3.95
Avoiding the void: cell-to-cell spread of human viruses. Nat Rev Microbiol (2008) 3.79
Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism. J Virol (2009) 3.67
Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. PLoS Pathog (2009) 3.66
Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe (2009) 3.58
Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion. Proc Natl Acad Sci U S A (2009) 3.47
Inefficient human immunodeficiency virus replication in mobile lymphocytes. J Virol (2006) 3.26
Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. J Virol (2009) 3.13
HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation. PLoS Pathog (2009) 2.92
Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion. PLoS Pathog (2009) 2.92
Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus. J Virol (2009) 2.87
Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. J Virol (1993) 2.63
Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain. Cell Host Microbe (2010) 2.44
Host restriction factors blocking retroviral replication. Annu Rev Genet (2008) 2.41
Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment. PLoS Pathog (2010) 2.12
The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu. J Virol (2009) 2.00
The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin. PLoS Pathog (2010) 1.94
Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles. PLoS Pathog (2010) 1.89
Tetherin restricts productive HIV-1 cell-to-cell transmission. PLoS Pathog (2010) 1.73
CD317/tetherin is enriched in the HIV-1 envelope and downregulated from the plasma membrane upon virus infection. J Virol (2010) 1.63
Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal. J Virol (2010) 1.47
A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle. J Virol (2009) 1.30
Tetherin: holding on and letting go. Cell (2010) 1.29
The IFITM proteins inhibit HIV-1 infection. J Virol (2010) 2.80
The interferon-inducible MxB protein inhibits HIV-1 infection. Cell Host Microbe (2013) 2.39
Methylation of Tat by PRMT6 regulates human immunodeficiency virus type 1 gene expression. J Virol (2005) 2.02
The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu. J Virol (2009) 2.00
An array microscope for ultrarapid virtual slide processing and telepathology. Design, fabrication, and validation study. Hum Pathol (2004) 1.98
IFITM proteins restrict viral membrane hemifusion. PLoS Pathog (2013) 1.86
Development and validation of a novel method to derive central aortic systolic pressure from the radial pressure waveform using an n-point moving average method. J Am Coll Cardiol (2011) 1.85
The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization. J Virol (2012) 1.64
Is HIV-1 RNA dimerization a prerequisite for packaging? Yes, no, probably? Retrovirology (2004) 1.59
Association of RNA helicase a with human immunodeficiency virus type 1 particles. J Biol Chem (2006) 1.37
Tetherin restricts direct cell-to-cell infection of HIV-1. Retrovirology (2010) 1.34
A riboswitch regulates RNA dimerization and packaging in human immunodeficiency virus type 1 virions. J Virol (2004) 1.30
Identification of an endocytic signal essential for the antiviral action of IFITM3. Cell Microbiol (2014) 1.23
Fiber-optic confocal reflectance microscope with miniature objective for in vivo imaging of human tissues. IEEE Trans Biomed Eng (2002) 1.23
Mutation of the SP1 sequence impairs both multimerization and membrane-binding activities of human immunodeficiency virus type 1 Gag. J Virol (2005) 1.21
Fiber optic confocal reflectance microscopy: a new real-time technique to view nuclear morphology in cervical squamous epithelium in vivo. Opt Express (2003) 1.21
Sequences downstream of the 5' splice donor site are required for both packaging and dimerization of human immunodeficiency virus type 1 RNA. J Virol (2003) 1.13
Comparative homegarden medical ethnobotany of Naxi healers and farmers in Northwestern Yunnan, China. J Ethnobiol Ethnomed (2014) 1.08
The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA. Retrovirology (2015) 1.06
ABCB6 mutations cause ocular coloboma. Am J Hum Genet (2012) 1.04
Tetherin inhibits prototypic foamy virus release. Virol J (2011) 1.02
In vitro identification and characterization of an early complex linking HIV-1 genomic RNA recognition and Pr55Gag multimerization. J Biol Chem (2004) 1.02
Negative effect of the M184V mutation in HIV-1 reverse transcriptase on initiation of viral DNA synthesis. Virology (2003) 1.02
The requirement of the DEAD-box protein DDX24 for the packaging of human immunodeficiency virus type 1 RNA. Virology (2008) 1.02
Coordinate roles of Gag and RNA helicase A in promoting the annealing of formula to HIV-1 RNA. J Virol (2010) 1.01
Deficient dimerization of human immunodeficiency virus type 1 RNA caused by mutations of the u5 RNA sequences. Virology (2002) 0.98
Novel frizzled-4 gene mutations in chinese patients with familial exudative vitreoretinopathy. Arch Ophthalmol (2010) 0.98
CT evaluation of cervical pedicle in a Chinese population for surgical application of transpedicular screw placement. Surg Radiol Anat (2008) 0.98
Substitutions in the reverse transcriptase and protease genes of HIV-1 subtype B in untreated individuals and patients treated with antiretroviral drugs. MedGenMed (2005) 0.97
The M184V mutation in HIV-1 reverse transcriptase reduces the restoration of wild-type replication by attenuated viruses. AIDS (2002) 0.95
Hydrogen sulfide regulates cardiac function and structure in adriamycin-induced cardiomyopathy. Circ J (2009) 0.94
Important role for the CA-NC spacer region in the assembly of bovine immunodeficiency virus Gag protein. J Virol (2004) 0.93
Design and evaluation of an ultra-slim objective for in-vivo deep optical biopsy. Opt Express (2010) 0.93
The packaging of human immunodeficiency virus type 1 RNA is restricted by overexpression of an RNA helicase DHX30. Virology (2007) 0.92
A novel frame-shift mutation in FRMD7 causes X-linked idiopathic congenital nystagmus in a Chinese family. Mol Vis (2011) 0.91
Effects of a single amino acid substitution within the p2 region of human immunodeficiency virus type 1 on packaging of spliced viral RNA. J Virol (2003) 0.91
Multidrug-resistant variants of HIV type 1 (HIV-1) can exist in cells as defective quasispecies and be rescued by superinfection with other defective HIV-1 variants. J Infect Dis (2009) 0.91
The MOV10 helicase inhibits LINE-1 mobility. J Biol Chem (2013) 0.90
Effects of Nanoanatase TiO2 on photosynthesis of spinach chloroplasts under different light illumination. Biol Trace Elem Res (2007) 0.90
Opposing effects of the M368A point mutation and deletion of the SP1 region on membrane binding of human immunodeficiency virus type 1 Gag. Virology (2005) 0.90
BMP9-induced osteogenetic differentiation and bone formation of muscle-derived stem cells. J Biomed Biotechnol (2012) 0.90
The HIV-1 Vpu viroporin inhibitor BIT225 does not affect Vpu-mediated tetherin antagonism. PLoS One (2011) 0.88
Tetherin and its viral antagonists. J Neuroimmune Pharmacol (2011) 0.87
HIV-1 Vpr activates both canonical and noncanonical NF-κB pathway by enhancing the phosphorylation of IKKα/β. Virology (2013) 0.86
The R362A mutation at the C-terminus of CA inhibits packaging of human immunodeficiency virus type 1 RNA. Virology (2005) 0.86
A HIV-1 minimal gag protein is superior to nucleocapsid at in vitro annealing and exhibits multimerization-induced inhibition of reverse transcription. J Biol Chem (2005) 0.86
The highly polymorphic cyclophilin A-binding loop in HIV-1 capsid modulates viral resistance to MxB. Retrovirology (2015) 0.86
High-throughput assay to identify inhibitors of Vpu-mediated down-regulation of cell surface BST-2. Antiviral Res (2011) 0.86
Antioxidant stress is promoted by nano-anatase in spinach chloroplasts under UV-B radiation. Biol Trace Elem Res (2007) 0.85
Prevalence of blood alcohol in fatal traffic crashes in Shanghai. Forensic Sci Int (2012) 0.85
Insulin-like growth factor II mRNA binding protein 1 associates with Gag protein of human immunodeficiency virus type 1, and its overexpression affects virus assembly. J Virol (2008) 0.85
DDX17 promotes the production of infectious HIV-1 particles through modulating viral RNA packaging and translation frameshift. Virology (2013) 0.85
Prognostic value of mitochondrial DNA content and G10398A polymorphism in non-small cell lung cancer. Oncol Rep (2013) 0.85
Leptin attenuates cerebral ischemia injury through the promotion of energy metabolism via the PI3K/Akt pathway. J Cereb Blood Flow Metab (2013) 0.85
Characterization of the interface of the bone marrow stromal cell antigen 2-Vpu protein complex via computational chemistry. Biochemistry (2012) 0.84
HIV-1 Vpr stimulates NF-κB and AP-1 signaling by activating TAK1. Retrovirology (2014) 0.84
Influences of calcium deficiency and cerium on growth of spinach plants. Biol Trace Elem Res (2007) 0.83
From promoting to inhibiting: diverse roles of helicases in HIV-1 Replication. Retrovirology (2012) 0.83
Association of the 5-HT2A receptor gene polymorphisms with obstructive sleep apnea hypopnea syndrome in Chinese Han population. Acta Otolaryngol (2011) 0.83
Suppression of an intrinsic strand transfer activity of HIV-1 Tat protein by its second-exon sequences. Virology (2003) 0.83
Expression and role of adiponectin receptor 1 in lipopolysaccharide-induced proliferation of cultured rat adventitial fibroblasts. Cell Biol Int (2010) 0.82
[Effects of hydrogen sulfide on vascular inflammation in pulmonary hypertension induced by high pulmonary blood flow: experiment with rats]. Zhonghua Yi Xue Za Zhi (2008) 0.82
Deletion of stem-loop 3 is compensated by second-site mutations within the Gag protein of human immunodeficiency virus type 1. Virology (2003) 0.81
Transmembrane interactions of HIV-1 Vpu and tetherin. Curr HIV Res (2012) 0.80
Insulin-like growth factor II mRNA binding protein 1 modulates Rev-dependent human immunodeficiency virus type 1 RNA expression. Virology (2009) 0.80
Vpu-mediated tetherin antagonism of ongoing HIV-1 infection in CD4(+) T-cells is not directly related to the extent of tetherin cell surface downmodulation. Virology (2011) 0.80
A synthesis of acetamidines. J Org Chem (2011) 0.80
The relationship between cancer pain and quality of life in patients newly admitted to Wuhan Hospice Center of China. Am J Hosp Palliat Care (2011) 0.79
Oxidative stress induced by lead in chloroplast of spinach. Biol Trace Elem Res (2008) 0.78
Inhibition of the connexin 43 elevation may be involved in the neuroprotective activity of leptin against brain ischemic injury. Cell Mol Neurobiol (2014) 0.78
Activation of the JAK-STAT3 pathway is associated with the growth of colorectal carcinoma cells. Oncol Rep (2013) 0.78
Extending the detection window of diazepam by directly analyzing its glucuronide metabolites in human urine using liquid chromatography-tandem mass spectrometry. J Chromatogr A (2012) 0.77
Zirconium oxide ceramic foam: a promising supporting biomaterial for massive production of glial cell line-derived neurotrophic factor. J Zhejiang Univ Sci B (2014) 0.77
Direct determination of diazepam and its glucuronide metabolites in human whole blood by μElution solid-phase extraction and liquid chromatography-tandem mass spectrometry. Forensic Sci Int (2013) 0.77
Extracorporeal shock wave treatment for non-inflammatory chronic pelvic pain syndrome: a prospective, randomized and sham-controlled study. Chin Med J (Engl) (2012) 0.77
Indole affects the formation of multicellular aggregate structures in Pantoea agglomerans YS19. J Gen Appl Microbiol (2016) 0.77
[Effect of agrochemicals and bio-control productions on soil nematode community dynamics]. Ying Yong Sheng Tai Xue Bao (2002) 0.77
Determination of ecgonine and seven other cocaine metabolites in human urine and whole blood by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry. Anal Bioanal Chem (2013) 0.77
Single crystal U-Pb zircon age and Sr-Nd isotopic composition of impactites from the Bosumtwi impact structure, Ghana: Comparison with country rocks and Ivory Coast tektites. Chem Geol (2010) 0.77
Mutations of the transcription factor FOXL2 gene in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome. Genet Test Mol Biomarkers (2009) 0.77
Neither ritonavir nor darunavir affect cell surface expression of tetherin or Vpu-mediated tetherin down-modulation. AIDS (2010) 0.77
Effects of lead on activities of photochemical reaction and key enzymes of carbon assimilation in spinach chloroplast. Biol Trace Elem Res (2008) 0.77
Nano-anatase relieves the inhibition of electron transport caused by linolenic acid in chloroplasts of spinach. Biol Trace Elem Res (2007) 0.76
Computational prediction of absorbance maxima for a structurally diverse series of engineered green fluorescent protein chromophores. J Phys Chem B (2008) 0.76
Effects of nano-anatase TiO2 on absorption, distribution of light, and photoreduction activities of chloroplast membrane of spinach. Biol Trace Elem Res (2007) 0.76
Effects of nano-anatase on spectral characteristics and distribution of LHCII on the thylakoid membranes of spinach. Biol Trace Elem Res (2007) 0.76
Fragile X mental retardation protein restricts replication of human immunodeficiency virus type 1. Virology (2009) 0.76
Outcomes of Adults with Acute Lymphoblastic Leukemia After Autologous Hematopoietic Stem Cell Transplantation and the Significance of Pretransplantation Minimal Residual Disease: Analysis from a Single Center of China. Chin Med J (Engl) (2015) 0.75
Localized leptin release may be an important mechanism of curcumin action after acute ischemic injuries. J Trauma Acute Care Surg (2013) 0.75
Substitutions in the Reverse Transcriptase and Protease Genes of HIV-1 Subtype B in Untreated Individuals and Patients Treated With Antiretroviral Drugs. J Int AIDS Soc (2005) 0.75
Promotion of energy transfer and oxygen evolution in spinach photosystem II by nano-anatase TiO2. Biol Trace Elem Res (2007) 0.75
The role of analgesic adjustment strategies in achieving analgesic efficacy in opioid-tolerant hospice patients in China. Am J Hosp Palliat Care (2013) 0.75
Facile fabrication and electrochemical oxidation of activated carbon microtube bundles for advanced all-solid-state supercapacitors. Nanotechnology (2020) 0.75
Forty cases of tumorous fever treated with TCM method of removing blood heat and dissipating blood stasis. J Tradit Chin Med (2006) 0.75
Synthesis and near-infrared fluorescence of K5NdLi2F10 nanocrystals and their dispersion with high doping concentration and long lifetime. Nanoscale (2014) 0.75
[Effect of maternal BDE-209 exposure on sexual development in male offspring rats]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi (2013) 0.75
Influences of lead (II) chloride on the nitrogen metabolism of spinach. Biol Trace Elem Res (2007) 0.75
Rapid separation and identification of Strychnos alkaloids metabolites in rats by ultra high performance liquid chromatography with linear ion trap Orbitrap mass spectrometry. J Sep Sci (2014) 0.75